Sign in

CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company

Solid Biosciences Inc.

Sign in to watch
Ticker
SLDB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
900943402
Phone
617-337-4680
Business address
500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
Former names
Solid Biosciences, LLC
  1. 4 Option exercise Director acquired 3,441 shares (option exercise)
  2. 4 Derivatives Options or other derivatives
  3. 4 Planned sale President and CEO sold 16,644 shares at $5.82 ($96,923)
  4. 4 Planned sale Chief Regulatory Officer sold 4,134 shares at $5.82 ($24,074)
  5. 4 Planned sale Director sold 2,658 shares at $5.82 ($15,478)
  6. 4 Planned sale Chief Technology Officer sold 3,616 shares at $5.82 ($21,057)
  7. 4 Planned sale Chief Operating Officer sold 7,469 shares at $5.82 ($43,494)
  8. 4 Planned sale Chief Medical Officer sold 0 shares
  9. 4 Planned sale CFO & Treasurer sold 5,404 shares at $5.82 ($31,469)
  10. 4 Planned sale Chief Operating Officer sold 18,894 shares at $6.44 ($121,713)
  11. 4 Planned sale President and CEO sold 48,913 shares at $6.44 ($315,093)
  12. 4 Planned sale Director sold 7,205 shares at $6.44 ($46,414)
  13. 4 Planned sale CFO & Treasurer sold 14,783 shares at $6.44 ($95,231)
  14. 4 Planned sale Chief Medical Officer sold 12,616 shares at $6.44 ($81,271)
  15. 4 Planned sale Chief Regulatory Officer sold 12,348 shares at $6.44 ($79,545)
  16. 4 Planned sale Chief Technology Officer sold 10,905 shares at $6.44 ($70,249)
  17. 4 Planned sale CFO & Treasurer sold 26,837 shares at $6.44 ($172,747)
  18. 4 Planned sale President and CEO sold 80,258 shares at $6.44 ($516,613)
  19. 4 Planned sale Chief Regulatory Officer sold 26,535 shares at $6.44 ($170,803)
  20. 4 Planned sale Chief Medical Officer sold 28,335 shares at $6.44 ($182,390)

Page 2 of 20 · 383 filings